​

Cardiovascular as well as chronic kidney disease is a major health burden
worldwide. CV risk factors tend to appear in clusters and their specific risk is
far beyond their additive effect. However, the impact of borderline conditions
of these traditional, but also non-traditional risk factors is less clear and needs
further research, specific evaluation, and treatment guidelines.

​

Early diagnosis of end organ damage is crucial in order to prevent it's
progression and aim to regress organ damage that has already developed.

​

Despite having many options for hypertension and cardiometabolic syndrome
treatment, control is achieved in a minority of patients. Adherence not only to
drug therapy but also to lifestyle change is poor and this is the main reason of
the global failure in prevention of end organ damage.

​

In this conference we are going to discuss all aspects of hypertension and other
CV risk factors, starting from prehypertension and other early metabolic
derangements because early diagnosis and intervention is crucial. New
diagnostic procedures will also be elaborated.

​

Importance of lifestyle change, proper blood pressure measurements with
the focus on newly developed methods will be part of our conference.

​

As we are at the new dawn of drug and intervention therapy for patients
with hypertension, cardiovascular risk factors and especially the
cardiometabolic syndrome, as well as for kidney patients and those with heart
failure, important sessions will focus on these new aspects.

​

Nurses, pharmacists, social workers, dieticians, and other allied
professionals are essential and should participate in this fight for wellness in
healthy and populations at risk. All these together with the physicians should
cooperate for maximal success in fighting the development of disease.

​

New technologies, both diagnostic and therapeutic, like Digital technology
are essential for diagnosis and optimal treatment and those will be discussed
thoroughly.

​

This is the year of new ESH guidelines on the management of hypertension.

Several round table sessions will be devoted to discussions of this desirable
awaited document. However, we will discuss also the controversial parts,
about future potential missing topics and new issues which should be
precisely defined.

​

As we did last year, this year we will organize several "hands-on" workshops,
in which experts will guide younger colleagues on many important practical
aspects of end organ evaluation.

​

"Meet the expert” sessions were very well attended last year, during all
coffee breaks, burning issues of cardiorenal and metabolic continuum will be
discussed.

​

The purpose of our meeting is to discuss in depth new mechanisms of
cardiovascular and renal damage, novel methods of diagnosis, leading to new
therapeutic approaches.

​

We cordially invite you to this conference with distinguished speakers
coming from all continents (apart from Antarctica).

​

You will enjoy with us the beauty of hypertension and cardiometabolic disase,
but also, friendship and our common commitment to improve lives of our

patients.